Biochemical markers in gastrointestinal malignancies.
The authors review the role of tumor markers in distinguishing benign from malignant conditions of the digestive tract. They also discuss the value of cancer markers to stratify patients in terms of their survival probability, to detect recurrence and to monitor treatment.
Cooper
E H
EH
Unit for Cancer Research, University of Leeds, England.
de Mello Júnior
J P
JP
Giles
G R
GR
D000209:Acute-Phase Proteins / Q000032:analysis; D015295:Antigens, Tumor-Associated, Carbohydrate / Q000032:analysis; D014408:Biomarkers, Tumor / Q000032:analysis*; D002272:Carcinoembryonic Antigen / Q000032:analysis; D005770:Gastrointestinal Neoplasms / Q000276:immunology*; D006801:Humans; D000509:alpha-Fetoproteins / Q000032:analysis
D000209:Acute-Phase Proteins; D015295:Antigens, Tumor-Associated, Carbohydrate; D014408:Biomarkers, Tumor; D002272:Carcinoembryonic Antigen; D000509:alpha-Fetoproteins